IsomAb Announces Close of £7.5 Million Financing to Accelerate Lead Candidate for Treatment of Peripheral Arterial Disease
Amount Raised
$7.5 Million
Round Type
Seed
NottinghamBiotechnologyHealth CareTherapeuticsBiopharmaInvestors
Description
IsomAb Ltd announced the closing of a £7.5 million Seed financing round to accelerate the development of its lead antibody, ISM-001, for the treatment of Peripheral Arterial Disease.
Quick answer
IsomAb raised $7.5 Million in a Seed round, dated February 20, 2024. Investors: Meif Proof Of Concept & Early Stage Fund, Scvc and Broadview Ventures. IsomAb is based in Nottingham, England, United Kingdom.
- How much did IsomAb raise?
- IsomAb raised $7.5 Million in a Seed round on February 20, 2024.
- Who invested in IsomAb?
- Meif Proof Of Concept & Early Stage Fund, Scvc and Broadview Ventures are named as investors in this round.
- What does IsomAb do?
- IsomAb Ltd is a UK-based biopharmaceutical company founded in 2022, specializing in isoform-specific disease modifying antibody treatments for serious and life-threatening diseases.
- Where is IsomAb based and how big is it?
- IsomAb is based in Nottingham, England, United Kingdom.
- Who are the decision-makers at IsomAb?
- Fundz holds 1 contact at IsomAb, including the Chief Development Officer (CDO). Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as IsomAb that raised within 45 days of this round, from Fundz verified event records.
- TORL BioTherapeutics raised $158M on April 4, 2024.
- AEON Biopharma raised $15M (Convertible Note) on March 21, 2024.
- Adipo Therapeutics raised $1.9M (Seed) on March 7, 2024.
- Parabilis Medicines raised $145M (Series E) on March 1, 2024.
- Crinetics Pharmaceuticals raised $350M on March 1, 2024.
- Denali Therapeutics raised $500M on February 29, 2024.
Who to call at IsomAb, and when
A new round usually means IsomAb is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day IsomAb raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IsomAb, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IsomAb. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IsomAb raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
IsomAb raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.